The role of clinical decision tools in chronic disease care Through RACGP Foundation-supported research, a GP academic is hoping to put an end to ‘blanket recommendations’ for chronic disease.
Large jump in medicinal cannabis use Therapeutic cannabis use has experienced a 1000% increase over the past three years, but two thirds of users still rely on illicit sources.
Burden of COVID and dementia set to grow: AIHW report Life expectancy for boys is increasing faster than for girls, as the true impact of the pandemic shows in the national agency’s latest health assessment.
More than 8m Australians have a long-term health condition: Census New Census data reinforces the college’s longstanding call for more general practice support, the RACGP’s Vice President says.
Considerations when selecting first-line analgesics SPONSORED: What should GPs be aware of when deciding whether to recommend paracetamol or another analgesic to patients?
‘Serious concerns’: RACGP criticises pharmacy pain trial Issues related to fragmentation and the quality of care provided were highlighted in a detailed college submission to the MSAC.
Research provides new blueprint for chronic pain care The framework promotes person-centred care and aims to support clinicians treating the one in five Australians living with chronic pain.
Research shows medicinal cannabis ‘boom’ in Australia More than 248,000 prescriptions have been approved over the past five years – 85% of which have been given out since January 2020.
First consensus statement on T2DM in young adults released The statement contains recommendations that differ from typical management guidelines, but also fails to acknowledge the role of GPs.
Chronic non-cancer pain in older people Dr David Liew talks with clinical pharmacology registrar Dr Gloria Wong about some of the challenges involved in the pharmacological management of chronic non-cancer pain in frail older people.